Longer-interval of Pfizer vaccine dose boosts antibody levels: Study

Clinical Trials |  News | 0 Comment | 23 Jul, 2021

Universities of Sheffield, Oxford, Liverpool, Newcastle, and Birmingham, with support from the UK Coronavirus Immunology...Read more

Nichi Glucan progresses to clinical studies in autism spectrum disorder

Clinical Trials |  Opinion | 0 Comment | 28 Jun, 2021

Beneficial effects in autism spectrum disorders of the Japanese food supplement Nichi-Glucan (www.nichiglucan.com), a bi...Read more

eTheRNA, VUB expand collaboration to engineer next-generation mRNA therapeutics

Clinical Trials |  News | 0 Comment | 23 Jun, 2021

eTheRNA immunotherapies, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and ...Read more

Medidata extends a secure platform for Decentralization of Clinical Trials (DCT)

Clinical Trials |  News | 0 Comment | 16 Jun, 2021

Medidata, a Dassault Systèmes company, announced the launch of the Medidata Decentralized Clinical Trials (D...Read more

Korea's IVI to develop adaptive Ph 1b/2a schistosomiasis vaccine trial

Clinical Trials |  News | 0 Comment | 03 Jun, 2021

The International Vaccine Institute (IVI) in South Korea has announced that the Bill & Melinda Gates Foundation has ...Read more

Tiziana seeks partner in Asia to enhance hepatocellular carcinoma treatment

Clinical Trials |  News | 0 Comment | 05 May, 2021

Tiziana Life Sciences plc, a UK based biotechnology company focused on innovative therapeutics for oncology, inflammatio...Read more

China explores new mode of pharmaceutical R&D

Clinical Trials |  News | 0 Comment | 03 May, 2021

Guangzhou Link Health Pharma Co., Ltd. (Link Health), based in China, and Australian firm George Clinical Pty Ltd (Georg...Read more

Fujifilm initiates new Ph III trial of Avigan for COVID-19 treatment in Japan

Clinical Trials |  News | 0 Comment | 21 Apr, 2021

FUJIFILM Toyama Chemical has announced the initiation of a new phase III clinical trial in Japan concerning its anti-inf...Read more

TrialWire launches StudyBoost, the Clinical trial insurance plan

Clinical Trials |  News | 1 Comment | 23 Mar, 2021

TrialWire(TM), the most secure digital Patient Recruitment Platform for trial rescue, announces the launch of StudyBoost...Read more

UK conducts innovative COVID-19 trials with deliberate volunteered infection

Clinical Trials |  News | 0 Comment | 02 Mar, 2021

United Kingdom government announced an investment of 33.6 million pounds ($43.5 million) in a study called “h...Read more

Panthera to evaluate AstraZeneca’s AZD7442 for the potential prevention of COVID-19

Clinical Trials |  News | 0 Comment | 30 Dec, 2020

Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase...Read more

Tychan to begin Ph 3 trial for mAb TY027 against COVID-19

Clinical Trials |  News | 0 Comment | 14 Dec, 2020

In June 2020, Tychan began its Phase 1 clinical safety trials in humans to evaluate TY027, a monoclonal antibo...Read more

Contract for innovative delivery system for COVID-19 vaccine

Clinical Trials |  News | 0 Comment | 16 Nov, 2020

Croda International Plc (“Croda” or “the Group”), the speciality chemical company that uses smar...Read more

CEPI funds Sichuan Clover for COVID-19 vaccine development

Clinical Trials |  News | 0 Comment | 05 Nov, 2020

CEPI, the Coalition for Epidemic Preparedness Innovations, based in Norway, has announced that it will fund the developm...Read more

Russia- Destination of choice for Asian pharma companies

Clinical Trials |  Opinion | 0 Comment | 03 Nov, 2020

Asian biotech industry has been experiencing an escalating boom over the past several years. Pharmaceutical companies ha...Read more

Daewoong pharma partners with Tufts medical center for Ph 2 trial with Niclosamide

Clinical Trials |  News | 0 Comment | 30 Oct, 2020

Daewoong Pharmaceutical announced on 26 Oct 2020 that the collaborative clinical research agreement betwe...Read more

Asieris announces approval for Ph 1 trial of bladder cancer drug in Australia

Clinical Trials |  News | 0 Comment | 29 Oct, 2020

Asieris Pharmaceuticals, a China-based biotech company specializing in the development and commercialization of new...Read more

APRINOIA announces NMPA approval to initiate Ph 3 clinical trial

Clinical Trials |  News | 0 Comment | 28 Oct, 2020

APRINOIA Therapeutics advancing a pipeline featuring diagnostic and therapeutic programs, collectively targeting brain d...Read more